Tien Luu has spent 20 years with Dassault Systemes BIOVIA (previously Accelrys) working with scientists in the life sciences, understanding how modelling and simulations are used to rationalize and accelerate drug design and development. She obtained her PhD in Medicinal Chemistry from the University of Wollongong, Australia, studying the synthesis and ration drug design of HIV inhibitors. Tien has worked with customers in training and pre-sales roles for over 16 years. She is now a part of the product management R&D team focused on Life Science Modeling and Simulation tools in BIOVIA.
In this webinar, Dassault Systèmes will present how combining molecular modelling and machine learning is essential for speeding up drug development, driving innovation and crucially supporting life science experts in their research.
This session will address:
● Leverage an open and scalable platform that brings together over 30 years of peer-reviewed research and world-class in silico techniques.
● Understand the benefits of structure-based design workflows and generative therapeutic design.
● Increase your understanding on new advances in Biologics excipients formulation
● Enhance team collaboration by enabling researchers to better share their data and make better-informed decisions in drug development.